NASDAQ:XENE - Xenon Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$10.35 +0.10 (+0.98 %)
(As of 07/20/2018 01:43 PM ET)
Previous Close$10.10
Today's Range$10.10 - $10.35
52-Week Range$2.10 - $11.00
Volume1,193 shs
Average Volume406,034 shs
Market Capitalization$142.43 million
P/E Ratio-6.02
Dividend YieldN/A
Beta0.64

Headlines

Xenon Pharmaceuticals (NASDAQ XENE) News Headlines

Source:
DateHeadline
Xenon Pharma inks $50M stock sales agreementXenon Pharma inks $50M stock sales agreement
seekingalpha.com - July 12 at 8:19 AM
Xenon Pharmaceuticals Announces At-The-Market Equity OfferingXenon Pharmaceuticals Announces At-The-Market Equity Offering
finance.yahoo.com - July 12 at 8:19 AM
$60,000.00 in Sales Expected for Xenon Pharmaceuticals Inc (XENE) This Quarter$60,000.00 in Sales Expected for Xenon Pharmaceuticals Inc (XENE) This Quarter
www.americanbankingnews.com - July 10 at 5:14 AM
Zacks: Brokerages Expect Xenon Pharmaceuticals Inc (XENE) to Post -$0.49 Earnings Per ShareZacks: Brokerages Expect Xenon Pharmaceuticals Inc (XENE) to Post -$0.49 Earnings Per Share
www.americanbankingnews.com - July 8 at 2:06 AM
A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The YearA Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year
feeds.benzinga.com - July 5 at 1:34 PM
Form SC 13G Xenon Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, LLCForm SC 13G Xenon Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, LLC
www.streetinsider.com - July 3 at 5:08 PM
Xenon Pharma +3.9% as Potiga gets orphan drug statusXenon Pharma +3.9% as Potiga gets orphan drug status
seekingalpha.com - June 25 at 5:37 PM
 Brokerages Anticipate Xenon Pharmaceuticals Inc (XENE) Will Announce Quarterly Sales of $60,000.00 Brokerages Anticipate Xenon Pharmaceuticals Inc (XENE) Will Announce Quarterly Sales of $60,000.00
www.americanbankingnews.com - June 22 at 1:08 AM
Zacks: Analysts Anticipate Xenon Pharmaceuticals Inc (XENE) to Announce -$0.49 Earnings Per ShareZacks: Analysts Anticipate Xenon Pharmaceuticals Inc (XENE) to Announce -$0.49 Earnings Per Share
www.americanbankingnews.com - June 20 at 9:16 PM
Benzingas Daily Biotech Pulse: vTv Swoons On Failed Alzheimers Trial, Regenxbio Gets FDA Fast Track For RGX-111Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111
feeds.benzinga.com - June 13 at 8:20 AM
Xenon Pharma continues northward march, up 15%Xenon Pharma continues northward march, up 15%
seekingalpha.com - June 12 at 5:03 PM
41 Stocks Moving In Tuesdays Mid-Day Session41 Stocks Moving In Tuesday's Mid-Day Session
feeds.benzinga.com - June 12 at 1:20 PM
Zacks: Analysts Anticipate Xenon Pharmaceuticals Inc (XENE) Will Announce Earnings of -$0.49 Per ShareZacks: Analysts Anticipate Xenon Pharmaceuticals Inc (XENE) Will Announce Earnings of -$0.49 Per Share
www.americanbankingnews.com - June 3 at 12:00 PM
Xenon Pharmaceuticals to Present at the Jefferies 2018 Healthcare ConferenceXenon Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
finance.yahoo.com - June 1 at 5:43 PM
Reader Inquiry: Can The Run Up Continue For Xenon Pharmaceuticals?Reader Inquiry: Can The Run Up Continue For Xenon Pharmaceuticals?
seekingalpha.com - May 30 at 5:19 PM
Xenon Pharmaceuticals Inc. (XENE) Expected to Post Quarterly Sales of $60,000.00Xenon Pharmaceuticals Inc. (XENE) Expected to Post Quarterly Sales of $60,000.00
www.americanbankingnews.com - May 19 at 3:56 AM
-$0.49 Earnings Per Share Expected for Xenon Pharmaceuticals Inc. (XENE) This Quarter-$0.49 Earnings Per Share Expected for Xenon Pharmaceuticals Inc. (XENE) This Quarter
www.americanbankingnews.com - May 17 at 10:36 AM
Blog Exposure - Xenon Announced Presentation of Positive XEN1101 TMS Pharmacodynamic Phase-1 Data at 14th Eilat ConferenceBlog Exposure - Xenon Announced Presentation of Positive XEN1101 TMS Pharmacodynamic Phase-1 Data at 14th Eilat Conference
finance.yahoo.com - May 17 at 8:24 AM
Xenon Pharma (XENE) Presents XEN1101 Interim Phase 1 Data At 14th Eilat Conference - SlideshowXenon Pharma (XENE) Presents XEN1101 Interim Phase 1 Data At 14th Eilat Conference - Slideshow
seekingalpha.com - May 16 at 5:40 PM
Are Xenon Pharmaceuticals Shares Making a Run?Are Xenon Pharmaceuticals Shares Making a Run?
www.msn.com - May 15 at 5:48 PM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and OverviewXenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview
www.nasdaq.com - May 15 at 8:29 AM
Xenon Pharma up 21% premarket on positive XEN1101 dataXenon Pharma up 21% premarket on positive XEN1101 data
seekingalpha.com - May 15 at 8:29 AM
Xenon Presents XEN901 Phase 1 Clinical Update and Supporting Pre-clinical Data at 14th Eilat ConferenceXenon Presents XEN901 Phase 1 Clinical Update and Supporting Pre-clinical Data at 14th Eilat Conference
feeds.benzinga.com - May 15 at 6:39 AM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of ...Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of ...
globenewswire.com - May 14 at 5:19 PM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of XEN1101 and XEN901 Presentations at 14th Eilat ConferenceXenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of XEN1101 and XEN901 Presentations at 14th Eilat Conference
finance.yahoo.com - May 14 at 5:19 PM
Xenon Pharmaceuticals Inc. Expected to Earn Q2 2018 Earnings of ($0.49) Per Share (XENE)Xenon Pharmaceuticals Inc. Expected to Earn Q2 2018 Earnings of ($0.49) Per Share (XENE)
www.americanbankingnews.com - May 14 at 1:17 AM
Xenon Pharmaceuticals (XENE) CEO Simon Pimstone on Q1 2018 Results - Earnings Call TranscriptXenon Pharmaceuticals' (XENE) CEO Simon Pimstone on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 5:52 PM
Xenon Pharmaceuticals (XENE) Rating Increased to Buy at Zacks Investment ResearchXenon Pharmaceuticals (XENE) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - May 10 at 3:23 PM
Edited Transcript of XENE earnings conference call or presentation 8-May-18 8:30pm GMTEdited Transcript of XENE earnings conference call or presentation 8-May-18 8:30pm GMT
finance.yahoo.com - May 10 at 8:26 AM
Xenon Pharmaceuticals (XENE) Issues Quarterly  Earnings ResultsXenon Pharmaceuticals (XENE) Issues Quarterly Earnings Results
www.americanbankingnews.com - May 9 at 1:58 PM
Xenon Pharmaceuticals: 1Q Earnings SnapshotXenon Pharmaceuticals: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 8:20 AM
Xenon Pharma beats by $0.27Xenon Pharma beats by $0.27
seekingalpha.com - May 8 at 5:38 PM
Xenon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate UpdateXenon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - May 8 at 5:38 PM
Xenon Pharmaceuticals (XENE) Upgraded by ValuEngine to "Buy"Xenon Pharmaceuticals (XENE) Upgraded by ValuEngine to "Buy"
www.americanbankingnews.com - May 2 at 1:37 PM
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results and Provide Corporate UpdateXenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results and Provide Corporate Update
finance.yahoo.com - May 1 at 5:17 PM
Xenon Pharmaceuticals Inc. (XENE) Expected to Announce Quarterly Sales of $100,000.00Xenon Pharmaceuticals Inc. (XENE) Expected to Announce Quarterly Sales of $100,000.00
www.americanbankingnews.com - May 1 at 2:02 AM
Xenon Pharmaceuticals (XENE) to Release Earnings on MondayXenon Pharmaceuticals (XENE) to Release Earnings on Monday
www.americanbankingnews.com - April 30 at 8:55 AM
Xenon Pharmaceuticals Inc. (XENE) Expected to Post Earnings of -$0.48 Per ShareXenon Pharmaceuticals Inc. (XENE) Expected to Post Earnings of -$0.48 Per Share
www.americanbankingnews.com - April 29 at 9:06 PM
Xenon Pharmaceuticals to Present at the 2018 Bloom Burton & Co. Healthcare Investor ConferenceXenon Pharmaceuticals to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference
finance.yahoo.com - April 25 at 5:28 PM
Xenon Pharmaceuticals (XENE) Receives "Buy" Rating from Canaccord GenuityXenon Pharmaceuticals (XENE) Receives "Buy" Rating from Canaccord Genuity
www.americanbankingnews.com - April 20 at 3:00 PM
 Analysts Anticipate Xenon Pharmaceuticals Inc. (XENE) Will Post Quarterly Sales of $100,000.00 Analysts Anticipate Xenon Pharmaceuticals Inc. (XENE) Will Post Quarterly Sales of $100,000.00
www.americanbankingnews.com - April 14 at 1:49 AM
Xenon Pharmaceuticals (XENE) Lifted to "Hold" at ValuEngineXenon Pharmaceuticals (XENE) Lifted to "Hold" at ValuEngine
www.americanbankingnews.com - April 2 at 10:26 PM
Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange ...Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange ...
globenewswire.com - March 30 at 5:29 PM
Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange Agreement with BVF Partners L.P.Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange Agreement with BVF Partners L.P.
finance.yahoo.com - March 28 at 5:17 PM
Zacks: Analysts Anticipate Xenon Pharmaceuticals Inc (XENE) Will Announce Earnings of -$0.48 Per ShareZacks: Analysts Anticipate Xenon Pharmaceuticals Inc (XENE) Will Announce Earnings of -$0.48 Per Share
www.americanbankingnews.com - March 26 at 11:08 PM
Jefferies Group Raises Xenon Pharmaceuticals (XENE) Price Target to $6.00Jefferies Group Raises Xenon Pharmaceuticals (XENE) Price Target to $6.00
www.americanbankingnews.com - March 22 at 3:02 PM
Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals as Chief Medical Officer - GlobeNewswire (press release)Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals as Chief Medical Officer - GlobeNewswire (press release)
globenewswire.com - March 14 at 8:35 AM
Xenon Pharmaceuticals (XENE) Names Dr. Ernesto Aycardi as Chief Medical OfficerXenon Pharmaceuticals (XENE) Names Dr. Ernesto Aycardi as Chief Medical Officer
www.streetinsider.com - March 13 at 7:15 PM
Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals as Chief Medical OfficerDr. Ernesto Aycardi Joins Xenon Pharmaceuticals as Chief Medical Officer
finance.yahoo.com - March 13 at 7:15 PM
Xenon Pharmaceuticals Inc (XENE) Forecasted to Earn Q1 2018 Earnings of ($0.49) Per ShareXenon Pharmaceuticals Inc (XENE) Forecasted to Earn Q1 2018 Earnings of ($0.49) Per Share
www.americanbankingnews.com - March 12 at 1:17 AM
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Featured Article: Earnings Per Share

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.